@FiercePharma: FDA close to resolving all cancer drug shortages; most stem from production halts to fix manufacturing issues. More | Follow @FiercePharma
@EricPFierce: ICYMI: Dr. Reddy's, Fujifilm pull plug on Japanese joint venture. Article | Follow @EricPFierce
@CarlyHFierce: European Commission to crack down on 'pay for delay,' reportedly fine 9 companies including Lundbeck, Merck KGaA, Ranbaxy. Article | Follow @CarlyHFierce
> GlaxoSmithKline's ($GSK) breast cancer drug Tykerb doesn''t boost survival rates in patients with gastric cancer compared with chemo alone, study finds. Report
> Boehringer Ingelheim and Eli Lilly ($LLY) launched an educational digital game to teach desktop and iPad users the importance of managing Type 2 diabetes. Report
> Courts in Ireland and the U.S. temporarily blocked Royalty Pharma's bid for Elan ($ELN). Report
> Adcock Ingram, the South African drugmaker that's up for sale, saw profits decline by 5.4% in the quarter. Report
@FierceMedDev: Stryker confronts mounting metal hip recall lawsuits. Story | Follow @FierceMedDev
@DamianFierce: St. Jude is targeting FDA approval for its renal denervation device with a new study. Report | Follow @DamianFierce
@MarkHFierce: Get your FMD Fierce 15 nominations in today. | Follow @MarkHFierce
@MichaelGFierce: ICYMI yesterday: Medtronic triggers summer PMA process for drug-eluting balloon. Story | Follow @MichaelGFierce
> Medtronic wins FDA nod, CE mark for angioplasty balloon. Story
> Zimmer boosts bone biz with German buyout. News
> Canon revs up MA med tech R&D operation. Report
> U of Minnesota fires competitive blast with new med devices center. Item
Biotech News
@FierceBiotech: Trending: Top 10 experimental cancer drugs - 2013. Special report | Follow @FierceBiotech
@JohnCFierce: Remember the Pluristem scandal last fall? FDA clamps clinical hold on Pluristem PhII stem cell trial. More | Follow @JohnCFierce
@RyanMFierce: J&J backs $biotech startup Protagonist in $14M financing. News | Follow @RyanMFierce
> FDA clamps clinical hold on Pluristem PhII stem cell trial. News
> R&D: Are true drug breakthroughs a thing of the past? More
> AstraZeneca tosses another PhIII failure onto the scrap heap. Report
> Akebia snags $41M financing in anemia-drug race with GlaxoSmithKline, others. Article
> Cardio3 tests Europe's appetite for biotech IPOs. Item
Biotech Research News
@EmilyMFierce: Alterations in one gene may drive allergic, autoimmune diseases. Story | Follow @EmilyMFierce
> $750,000 in grants available to scientific researchers under new program. Report
> NIH lays out effects of sequestration on biomedical research. News
> New agent stops replication of hep C virus in preclinical studies. Article
> Pfizer taps UCSF for small-molecule drug discovery. Story
Pharma Manufacturing News
> CorePharma gets closeout letter for NJ plant. Report
> WSJ: Novartis looks to unload CMO LTS Lohmann. Article
> FDA close to resolving all cancer drug shortages. Story
> Explosion, fire at Teva plant kills one, injures 30. More
And Finally... Long-term cancer survivors need special treatment and often aren't getting it. Report